Skip to main content
Log in

The Stockholm breast cancer screening trial — 5-year results and stage at discovery

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

In screening programmes it is important to assess a preliminary effectiveness of the screening method as soon as possible in order to forecast survival figures. In March 1981 a controlled single-view mammographic screening trial for breast cancer was started in the south of Stockholm. The population invited for screening mammography consisted of 40,000 women aged 40–64 years, and 20,000 women served as a well-defined control group. The main aim of the trial was to determine whether repeated mammographic screening could reduce the mortality in the study population (SP) compared to the control population (CP).

The cumulative number of advanced mammary carcinomas in the screening and the control populations from the first five years of screening have shown a tendency towards more favourable stages in the screened population aged 40–64 years. A breakdown by age suggests an effect in age group 50–59 years, but not yet in age groups 40–49 and 60–64 years.

When comparing the rates of stage II+ cancer, an increased number is found in the study group. As the total rate of breast cancer is higher in SP than in CP, there ought to be a concealed group of stage II+ cancers in the CP which makes the comparison biased. A new approach has been designed, where an estimation of the ‘hidden’ number of stage II+ cancers in CP is added to the clinically detected cases, and in this respect a comparison has shown a decrease in the cumulative number of advanced cancers in the SP in relation to the CP (p<0.05). According to this it could be important to add the estimated number of undetected, hidden cases in the control group in order to utilize the difference in detection rate in the screening- and control group respectively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Tabár L, Fagerberg G, Gad A, Baldetorp L, Holmberg LH, Gröntoft D, Ljungquist U, Lundström B, Månsson IC, Eklund G, Pettersson F, Day NF: Reduction in mortality from breast cancer after mass screening with mammography. Lancet i 829–832, 1985

    Google Scholar 

  2. Lundgren B, Jakobsson S: Single-view mammography, a simple and efficient approach to breast cancer screening. Cancer 30: 1124–1129, 1976

    Google Scholar 

  3. Frisell J, Glas U, Hellström L, Somell A: Randomized mammographic screening for breast cancer in Stockholm. Breast Cancer Res Treat 8: 45–54, 1986

    PubMed  Google Scholar 

  4. Tabár L, Åkerlund F, Gad A: Five year experience with single view Mammography Randomized Controlled screening in Sweden. Recent Results Cancer Res 90: 105–113, 1984

    PubMed  Google Scholar 

  5. Moskowitz M: Screening for breast cancer: How effective are our tests? A critical review. Cancer J Clin 33: 26–39, 1983

    Google Scholar 

  6. Lundgren B: Diagnosis and screening in breast cancer: A review. Eur J Cancer Clin Oncol 19: 1709–1710, 1983

    PubMed  Google Scholar 

  7. Shapiro S, Strax P, Venet L: Periodic breast cancer screening in reducing mortality from breast cancer. JAMA 215: 1777–1785, 1971

    PubMed  Google Scholar 

  8. Beahrs OH, Smart CR: Diagnosis of minimal breast cancers in the BDDOP. The 66 questionable cases. Cancer 848–850, 1979

  9. Andersson I: Radiographic screening for breast carcinoma. Program and primary findings in 45–69 year old women. Acta Radiol Diagn (Stockholm) 22: 185–194, 1981

    Google Scholar 

  10. Prorok PC, Chamberlain J, Day NE, Hakana M, Miller AB: UICC workshop on the evaluation of screening programmes for cancer. Int J Cancer 34: 1–4, 1984

    PubMed  Google Scholar 

  11. Rutqvist LE, Wallgren A, Nilsson B: Is breast cancer a curable disease? A study of 14,731 women with breast cancer from the cancer Registry of Norway. Cancer 53(8): 1793–1800, 1984

    PubMed  Google Scholar 

  12. Hakulinen T, Pukkala E, Hakama M, Lehtonen M, Saxén E, Teppo L: Survival of cancer patients in Finland in 1953–1974. Ann of Clin Res 13: suppl 31, 1981

    Google Scholar 

  13. Tabár L, Fagerberg CJG, Day NE: The results of periodic one-view mammographic screening in a randomized controlled trial in Sweden. Part II. Evaluation of the results. Manuscript presented at the UICC Workshop on Screening for Breast Cancer, Helsinki, April 5–7, 1986

  14. Cancer, SOU 1984: 67. Liber 1984

  15. Andersson I: Mammographic screening for breast carcinoma. A cross-sectional randomized study of 45–69 year old women. Thesis, Malmö, 1980

  16. Bjurstam N, Cahlin E, Eriksson O, Hafström L-O, Rudenstam C-M, Säve-Söderberg J: Breast Cancer Screening Project, Göteborg, Sweden. An efficient program for breast screening by mammography. Experiences from two screening rounds. In abstract: 4th EORTC Breast Cancer Working Conference, London, July 1987

  17. Frisell J, Eklund G, Hellström L, Somell A: Analysis of interval carcinomas in a randomized screening trial in Stockholm. Breast Cancer Res Treat 3: 219–25, 1987

    Google Scholar 

  18. von Rosen A, Erhardt K, Hellström L, Somell A, Auer G: Assessment of malignancy potential in so-called interval mammary carcinomas. Breast Cancer Res Treat 6: 221–27, 1985

    PubMed  Google Scholar 

  19. Shapiro S, Venet W, Strax P, Venet L, Roeser R: Selection follow-up and analysis in the Health Insurance Plan Study: A randomized trial with breast cancer screening. NCI Monogr 67: 65–74, 1985

    Google Scholar 

  20. Collette HJA, Day NE, Rombach JJ, De Waard F: Evaluation of screening for breast cancer in a non-randomized study (the DOM Project) by means of a case control study. Lancet i: 1224–26, 1984

    Google Scholar 

  21. Verbeek ALM, Hendriks JHCL, Holland R, Mravunac M, Sturmans F, Day NE: Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen Project 1975–1981. Lancet i: 1222–24, 1984

    Google Scholar 

  22. Chamberlain J, Coleman D, Ellman R, Moss SM: First results on mortality reduction in the Uk trial of early detection of breast cancer. Lancet ii: 411–16, 1988

    Google Scholar 

  23. Day NE, Walter SD: Simplified models of screening for chronic disease: Estimation procedures from mass screening programmes. Biometrics 40: 1–4, 1984

    PubMed  Google Scholar 

  24. Wallgren A, Silfverswärd C, Eklund G: Prognostic factors in mammary carcinoma. Acta Radiol Ther Phys Biol 15: 1–6, 1976

    PubMed  Google Scholar 

  25. Tabár L, Gad A, Holmberg L, Ljungquist U: Significant reduction in advanced breast cancer. Diagn Imag Clin Med 54: 158–164, 1985

    Google Scholar 

  26. Langlands AO, Kerr GR: Prognosis in breast cancer: The relevance of clinical staging. Clin Radiol 29: 599–606, 1978

    PubMed  Google Scholar 

  27. Fagerberg G, Baldetorp L, Gröntoft O, Lundström B, Månsson JC, Nordenskjöld B: Effects of repeated mammographic screening on breast cancer stage distribution. Acta Radiologica 24: 465–73, 1985

    Google Scholar 

  28. Tabar L, Dean P: The control of breast cancer through mammography screening. What is the evidence? Radiol Clin Am 25: 993–1005, 1987

    Google Scholar 

  29. Andersson I, Janzon L, Sigfússon BF: Mammographic breast cancer screening — a randomized trial in Malmö, Sweden. Maturitas 7: 21–29, 1985

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frisell, J., Eklund, G., Hellström, L. et al. The Stockholm breast cancer screening trial — 5-year results and stage at discovery. Breast Cancer Res Tr 13, 79–87 (1989). https://doi.org/10.1007/BF01806553

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01806553

Key words

Navigation